Mitsue Saito

3.3k total citations
119 papers, 1.7k citations indexed

About

Mitsue Saito is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mitsue Saito has authored 119 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 35 papers in Cancer Research and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mitsue Saito's work include Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (18 papers) and Breast Lesions and Carcinomas (16 papers). Mitsue Saito is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (18 papers) and Breast Lesions and Carcinomas (16 papers). Mitsue Saito collaborates with scholars based in Japan, United States and Denmark. Mitsue Saito's co-authors include Yoshiya Horimoto, Atsushi Arakawa, Kenichi Inoue, Yasuhiro Yanagita, Chiyoe Kitagawa, Kenjiro Aogi, Takashi Ogura, Hiroshi Sakai, Hirohisa Yoshizawa and Ikuo Sekine and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mitsue Saito

109 papers receiving 1.6k citations

Peers

Mitsue Saito
Som D. Mukherjee Canada
Katherine C. Fuh United States
Laura Kruper United States
Nevena Damjanov United States
Helen Krontiras United States
Jeroen Hagendoorn Netherlands
Alessia Nottegar Italy
Safi Shahda United States
Jean Trédaniel France
Judith de Vos‐Geelen Netherlands
Som D. Mukherjee Canada
Mitsue Saito
Citations per year, relative to Mitsue Saito Mitsue Saito (= 1×) peers Som D. Mukherjee

Countries citing papers authored by Mitsue Saito

Since Specialization
Citations

This map shows the geographic impact of Mitsue Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsue Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsue Saito more than expected).

Fields of papers citing papers by Mitsue Saito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsue Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsue Saito. The network helps show where Mitsue Saito may publish in the future.

Co-authorship network of co-authors of Mitsue Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsue Saito. A scholar is included among the top collaborators of Mitsue Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsue Saito. Mitsue Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yanagihara, Hiromi, Yoshiya Horimoto, Tatsuhiko Imaoka, et al.. (2023). Azithromycin induces read-through of the nonsense Apc allele and prevents intestinal tumorigenesis in C3B6F1 Apc/+ mice. Biomedicine & Pharmacotherapy. 164. 114968–114968. 5 indexed citations
3.
Horimoto, Yoshiya, Kaori Denda‐Nagai, Haruhiko Fujihira, et al.. (2023). Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer. Scientific Reports. 13(1). 5281–5281. 5 indexed citations
4.
5.
Horimoto, Yoshiya, et al.. (2022). Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer. Breast Cancer Research and Treatment. 196(2). 291–298. 12 indexed citations
6.
Nishimura, Yukiko, K. Nagata, Mayumi Nishimura, et al.. (2022). Brca1L63X/+ rat is a novel model of human BRCA1 deficiency displaying susceptibility to radiation‐induced mammary cancer. Cancer Science. 113(10). 3362–3375. 11 indexed citations
7.
8.
Takahashi, Yuka, Yoshiya Horimoto, Kaoru Mogushi, et al.. (2020). Short somatic alterations at the site of copy number variation in breast cancer. Cancer Science. 112(1). 444–453. 7 indexed citations
9.
Horimoto, Yoshiya, et al.. (2020). High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer. Breast Cancer Research and Treatment. 183(1). 41–48. 10 indexed citations
10.
Jiang, Zefei, Takahiro Nakayama, Seigo Nakamura, et al.. (2020). LBA 1 Baseline characteristics of patients from Asia enrolled in monarchE, evaluating abemaciclib in high risk early breast cancer. Annals of Oncology. 31. S1241–S1241. 1 indexed citations
11.
Horimoto, Yoshiya, Masahiko Tanabe, Kaoru Mogushi, et al.. (2019). Estrogen Receptor-positive Ductal Carcinoma In Situ Frequently Overexpresses HER2 Protein Without Gene Amplification. The American Journal of Surgical Pathology. 43(9). 1221–1228. 6 indexed citations
12.
Horimoto, Yoshiya, et al.. (2019). Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer. Medical Oncology. 36(10). 89–89. 14 indexed citations
13.
Iwata, Hiroji, Norikazu Masuda, Daigo Yamamoto, et al.. (2017). Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 162(3). 501–510. 10 indexed citations
14.
15.
Horimoto, Yoshiya, Atsushi Arakawa, Masahiko Tanabe, et al.. (2015). Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients. Journal of Clinical Pathology. 68(10). 825–829. 10 indexed citations
16.
Horimoto, Yoshiya, Atsushi Arakawa, Masahiko Tanabe, et al.. (2014). Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer. BMC Cancer. 14(1). 550–550. 22 indexed citations
17.
Tajima, Miyuki, et al.. (2012). Risk Factor for Peripheral Neuropathy Induced by Paclitaxel in Patients with Breast Cancer. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 38(6). 359–364. 1 indexed citations
18.
Takahashi, Yuka, Miwako Iwai, Taketo Kawai, et al.. (2011). Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. Breast Cancer. 19(3). 242–252. 69 indexed citations
19.
Nakai, Katsuya, et al.. (2010). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 19(2). 159–163. 2 indexed citations
20.
Kris, Mark G., Maurizio Tonato, Emilio Bria, et al.. (2010). Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer. 19(S1). 25–32. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Som D. Mukherjee Breakdown of academic impact, for papers by Katherine C. Fuh Breakdown of academic impact, for papers by Laura Kruper Breakdown of academic impact, for papers by Nevena Damjanov Breakdown of academic impact, for papers by Helen Krontiras Breakdown of academic impact, for papers by Jeroen Hagendoorn Breakdown of academic impact, for papers by Alessia Nottegar Breakdown of academic impact, for papers by Safi Shahda Breakdown of academic impact, for papers by Jean Trédaniel Breakdown of academic impact, for papers by Judith de Vos‐Geelen
Rankless by CCL
2026